Lung Cancer Screening, Diagnosis, and Interventions
Lung cancer remains the leading cause of cancer-related mortality worldwide, with early detection playing a critical role in improving survival rates. This session discusses the implementation and outcomes of low-dose computed tomography (LDCT) screening programs for high-risk populations. Emphasis is placed on advancements in imaging techniques, liquid biopsy, and biomarker-driven diagnostics. Treatment strategies, including minimally invasive surgical interventions, radiation therapy, and targeted therapies, are reviewed. The role of interventional pulmonology in diagnostic procedures such as EBUS and navigational bronchoscopy is explored. Discussions also cover patient selection, risk stratification, and shared decision-making in screening programs. This session provides a comprehensive overview of modern approaches to lung cancer detection and personalized intervention planning.